Modern treatment of infection and ischaemia to reduce major amputation in the diabetic foot

Current Pharmaceutical Design

Volumn 19, Issue 27, 2013, Pages 5008-5015

  Edmonds, Michael ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Amputation; Foot; Infection; Ulcer

Indexed keywords

CEFALEXIN; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ERTAPENEM; EVEROLIMUS; FUSIDATE SODIUM; LEVOFLOXACIN; LINEZOLID; METRONIDAZOLE; OFLOXACIN; PACLITAXEL; PEXIGANAN; PIPERACILLIN PLUS TAZOBACTAM; PSEUDOMONIC ACID; RIFAMPICIN; SULTAMICILLIN; TIMENTIN; TRIMETHOPRIM;

ANGIOPLASTY; ANTIBIOTIC THERAPY; ARTICLE; BYPASS SURGERY; CONSERVATIVE TREATMENT; DIABETIC FOOT; DISEASE SEVERITY; DRUG ELUTING STENT; FOOT AMPUTATION; FOOT CARE; HUMAN; INFECTION; ISCHEMIA; OSTEOMYELITIS; PATHOGENESIS; PRIORITY JOURNAL; REVASCULARIZATION; SOFT TISSUE INFECTION; ULCER;

ANTI-BACTERIAL AGENTS; DIABETIC FOOT; DISEASE SUSCEPTIBILITY; DRUG RESISTANCE, BACTERIAL; FOOT; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INDIVIDUALIZED MEDICINE; ISCHEMIA; OPPORTUNISTIC INFECTIONS; OSTEOMYELITIS; PRACTICE GUIDELINES AS TOPIC; VASCULAR SURGICAL PROCEDURES;

EID: 84881363190     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319270021     Document Type: Article

References (64)

1. Frykberg RG, Wittmayer B, Zgonis T. Surgical management of diabetic foot infections and osteomyelitis. Clin Podiatr Med Surg 2007; 24: 469-82
2. Fincke BG, Miller DR, Turpin R. A classification of diabetic foot infections using ICD-9-CM codes: application to a large computerized medical database. BMC Health Serv Res 2010; 10: 192.
3. Lipsky BA, Berendt AR, Cornia PB, et al. Infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54(12): e132-73.
4. Lipsky BA, Berendt AR, Cornia PB, et al. Executive summary: 2012 infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54(12): 1679-84.
5. Lipsky BA, Peters EJ, Berendt AR, et al. International Working Group on Diabetic Foot. Specific guidelines for the treatment of diabetic foot infections 2011. Diabetes Metab Res Rev 2012; 28 Suppl 1: 234-5. doi: 10.1002/dmrr.2251.
6. Lipsky BA, Peters EJ, Senneville E, et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev 2012; 28 Suppl 1: 163-78. doi: 10.1002/dmrr.2248.
7. Nabuurs-Franssen MH, Huijberts MS, Nieuwenhuijzen Kruseman AC, Willems J, Schaper NC. Health-related quality of life of diabetic foot ulcer patients and their caregivers. Diabetologia 2005; 48(9): 1906-1910.
8. Ragnarson Tennvall G, Apelqvist J. Health-economic consequences of diabetic foot lesions. Clin Infect Dis 2004; 39 Suppl 2: S132-39.
9. Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007 Jan; 50(1): 18-25. Epub 2006 Nov 9.
10. Prompers L, Schaper N, Apelqvist J, et al. Outcomes and predictors of outcome in individuals with diabetic foot ulcers. Focus on the differences between individuals with and without peripheral arterial disease. Diabetologia 2008 May; 51(5): 747-55. Epub 2008 Feb 23.
11. Gershater MA, Löndahl M, Nyberg P, et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 2009; 52(3): 398-407. Epub 2008 Nov 27.
12. Apelqvist J, Elgzyri T, Larsson J, Löndahl M, Nyberg P, Thörne J. Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients J Vasc Surg 2011; 53(6): 1582-8. e2. Epub 2011 Apr 23.
13. Turina M, Fry DE, Polk HC Jr. Links Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 2005; 33(7): 1624-33.
14. Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974; 23: 9-15.
15. Armstrong DG, Lavery LA, Sariaya M, Ashry HJ. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. Foot Ankle Surg 1996; 35(4): 280-3
16. Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 2007; 45(9): 2819-28. Epub 2007 Jul 3
17. M Edmonds, The treatment of diabetic foot infections: focus on ertapenem. Vasc Health Risk Manag 2009; 5: 949-63.
18. Nelson EA, O'Meara S, Golder S, Dalton J, Craig D, Iglesias C. DASIDU Steering Group. J Clin Microbiol 2007 S; 45(9): 2819-28. Epub 2007 Jul 3 Systematic review of antimicrobial treatments for diabetic foot ulcers. Diabet Med 2006; 23(4): 348-59
19. Joseph WS, Lipsky BA. Medical therapy of diabetic foot infections. J Vasc Surg 2010; 52(3 Suppl): 67S-71S.
20. Peters EJ, Lavery LA, Armstrong DG. Diabetic lower extremity infection: influence of physical, psychological, and social factors. J Diabetes Complications 2005; 19: 107-12.
21. Bader MS. Diabetic foot infection Am Fam Physician 2008; 1; 78(1): 71-9.
22. Clay PG, Graham MR, Lindsey CC, Lamp KC, Freeman C, Glaros A. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males. Am J Geriatr Pharmacother 2004; 2(3): 181-9.
23. Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 2005; 366(9498): 1695-1703.
24. Harkless L, Boghossian J, Pollak R, et al. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. Surg Infect (Larchmt) 2005; 6(1): 27-40.
25. Tan JS, Friedman NM, Hazelton-Miller C, Flanagan JP, File TM Jr. Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation? Clin Infect Dis 1996; 23: 286-91.
26. Krause FG, deVries G, Meakin C, Kalla TP, Younger AS. Outcome of transmetatarsal amputations in diabetics using antibiotic beads. Foot Ankle Int 2009; 30: 486-93.
27. Aragón-Sánchez J. Clinical-pathological characterization of diabetic foot infections: grading the severity of osteomyelitis. Int J Low Extrem Wounds 2012; 11(2): 107-12.
28. Game F, Jeffcoate W. Primarily non-surgical management of osteomyelitis of the foot in diabetes. Diabetologia 2008 Jun; 51(6): 962-7.
29. Taylor SM, Johnson BL, Samies NL, et al. Contemporary management of diabetic neuropathic foot ulceration: a study of 917 consecutively treated limbs Am Coll Surg 2011; 212(4): 532-45; discussion 546-8.
30. Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre randomised controlled trial. Lancet 2005; 366: 1704-10.
31. Löndahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 2010; 33: 998-1003.
32. Hinchliffe RJ, Andros G, Apelqvist J, et al. Diabetes Metab Res Rev 2012 Feb; 28 Suppl 1: 179-217. doi: 10.1002/dmrr.2249.
33. Schaper NC, Andros G, Apelqvist J, et al. International Working Group on Diabetic foot. Specific guidelines for the diagnosis and treatment of peripheral arterial disease in a patient with diabetes and ulceration of the foot 2011. Diabetes Metab Res Rev 2012; 28 Suppl 1: 236-7. doi: 10.1002/dmrr.2252 Chapter V: Diabetic foot.
34. Lepäntalo M, Apelqvist J, Setacci C, et al. The Diabetic Foot Eur J Vasc Endovasc Surg 2011; 42 Suppl 2: S60-74.
35. The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J 2011; 32: 2851-2906doi: 10.1093/eurheartj/ehr211
36. Faglia E, Mantero M, Caminiti M, et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 2002; 252(3): 225-325.
37. Faglia E, Dalla Paola L, Clerici G, et al. Peripheral angioplasty as the first-choice revascularisation procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg 2005; 29(6): 620-7.
38. Faglia E, Clerici G, Losa S, et al. Limb revascularisation feasibility in diabetic patients with critical limb ischemia: results from a cohort of 344 consecutive unselected diabetic patients evaluated in 2009. Diabetes Res Clin Pract 2012; 95(3): 364-71.
39. Cardaioli P, Rigatelli G, Dell'avvocata F, et al. Endovascular treatment of diabetic foot syndrome: results from a single center prospective registry using mixed coronary and peripheral techniques and equipment J Interv Cardiol 2011; 24(6): 562-8. doi: 10.1111/j.1540-8183.2011.00676.x. Epub 2011 Sep 12.
40. Mendiz OA, Fava CM, Valdivieso LR, Lev GA, Villagra LG. Angioplasty for treatment of isolated below-the-knee arterial stenosis in patients with critical limb ischemia. Angiology 2011; 62(5): 359-64.
41. Schmidt A, Piorkowski M, Werner M, et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol 2011; 58(11): 1105-9.
42. Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg 2012; 55(2): 390-8.
43. Peeters P, Verbist J, Keirse K, Callaert J, Deloose K, Bosiers M. Endovascular procedures and new insights in diabetic limb salvage. J Cardiovasc Surg (Torino) 2012; 53(1): 31-7.
44. Gandini R, Uccioli L, Spinelli A, et al. Alternative Techniques for Treatment of Complex Below-the Knee Arterial Occlusions in Diabetic Patients With Critical Limb Ischemia. Cardiovasc Intervent Radiol 2012 Jan 26.
45. Pomposelli FB, Kansal N, Hamdan AD, et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 2003; 37(2): 307-15.
46. Slim H, Tiwari A, Ahmed A, Ritter JC, Zayed H, Rashid H. Distal versus ultra distal bypass grafts: amputation-free survival and patency rates in patients with critical leg ischaemia. Eur J Vasc Endovasc Surg 2011; 42(1): 83-8.
47. El Sakka K, Fassiadis N, Gambhir RP, et al. An integrated care pathway to save the critically ischaemic diabetic foot. Int J Clin Pract 2006; 60: 667-9.
48. Armstrong DG, Bharara M, White M, et al. The Impact and Outcomes of Establishing an Integrated Interdisciplinary Surgical Team to Care for The Diabetic Foot. Diabetes Metab Res Rev 2012 Mar 19. doi: 10.1002/dmrr.2299. Epub ahead of print.
49. Venermo M, Biancari F, Arvela E, et al. The role of chronic kidney disease as a predictor of outcome after revascularisation of the ulcerated diabetic foot. Diabetologia 2011; 54(12): 2971-7.
50. Lepäntalo M, Fiengo L, Biancari F. Peripheral arterial disease in diabetic patients with renal insufficiency: Diabetes Metab Res Rev 2012; 28 Suppl 1: 40-5. doi: 10.1002/dmrr.2233.
51. McArthur CS, Sheahan MG, Pomposelli FB Jr, et al. Infrainguinal revascularisation after renal transplantation. J Vasc Surg 2003; 37(6): 1181-5.
52. Ramdev P, Rayan SS, Sheahan M, et al. A decade experience with infrainguinal revascularisation in a dialysis-dependent patient population. J Vasc Surg 2002; 36(5): 969-74.
53. Edmonds M, Foster AVM. Reduction of major amputations in the diabetic ischemic foot: a strategy to 'take control' with conservative care as well as revascularisation. VASA 2001; 58 (suppl): 6-14.
54. Apelqvist J, Bakker K, Van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 2000; 16 Suppl 1: S84.
55. Krishnan S. et al. Reduction in Diabetic Amputations Over 11 years in a Defined U.K. population Diabetes Care 2008; 31: 192.
56. Canavan R. et al. Diabetes and Nondiabetes Related Lower Extremity Amputation Incidence Before and After the Introduction of Better Organized Diabetes Foot Care Diabetes Care 2008; 31: 3.
57. Anichini R, Zecchini F, Cerretini I, et al. Improvement of diabetic foot care after the Implementation of the International Consensus on the Diabetic Foot (ICDF): results of a 5-year prospective study. Diabetes Res Clin Pract 2007; 75: 153-8.
58. Trautner C, Haastert B, Spraul M, Giani G, Berger M. Unchanged incidence of lower-limb amputations in a German city, 1990-1998. Diabetes Care 2001; 24: 855-9.
59. Trautner C, Haastert B, Mauckner P, Gätcke LM, Giani G. Reduced Incidence of Lower-Limb Amputations in the Diabetic Population of a German City, 1990-2005: Results of the Leverkusen Amputation Reduction Study (LARS). Diabetes Care 2007; 30: 2633-7.
60. Eskelinen E, Eskelinen A, Alback A, Lepantalo M. Major amputation incidence decreases both in non-diabetic and in diabetic patients in Helsinki. Scand J Surg 2006; 95: 185-9.
61. Rogers LC, Andros G, Caporusso J, Harkless LB, Mills JL Sr, Armstrong DG. Toe and flow: essential components and structure of the amputation prevention team J Vasc Surg 2010; 52(3 Suppl): 23S-27S.
62. Evans KK, Attinger CE, Al-Attar A, et al. J Diabetes Complications 2011; 25(4): 227-31.
63. Caravaggi C. Integrated surgical protocol for the treatment of the infected diabetic foot. J Cardiovasc Surg (Torino) 2012; 53(1): 23-30.
64. Chong-Chi C, Chen-Ling H, Shuen-Fu W, Lei-Ming S, Yu-Lien C, Feng-Chou T. A multidisciplinary diabetic foot ulcer treatment programme significantly improved the outcome in patients with infected diabetic foot ulcers. J Plastic, Reconstructive Aesthetic Surgery Volume 2011; 64(7): 867-72.